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Clinical, laboratory and pathological findings in dogs
experimentally infected with Angiostrongylus vasorum
Abstract
The aim of this comparative study was to investigate the development of clinical signs and
accompanying haematological, coproscopic and pathological findings as a basis for the monitoring of
health condition of Angiostrongylus vasorum infected dogs. Six beagles were orally inoculated with 50
(n = 3) or 500 (n = 3) A. vasorum third stage larvae (L3) obtained from experimentally infected
Biomphalaria glabrata snails. Two dogs were treated with moxidectin/imidacloprid spot-on solution and
two further dogs with an oral experimental compound 92 days post infection (dpi), and were necropsied
166 dpi. Two untreated control dogs were necropsied 97 dpi. Prepatency was 47-49 days. Dogs
inoculated with 500 L3 exhibited earlier (from 42 dpi) and more severe respiratory signs. Clinical signs
resolved 12 days after treatment and larval excretion stopped within 20 days in all four treated dogs.
Upon necropsy, 10 and 170 adult worms were recovered from the untreated dogs inoculated with 50 and
500 L3, respectively. Adult worms were also found in two treated dogs, in the absence of L1 or eggs.
Despite heavy A. vasorum infection load and severe pulmonary changes including vascular thrombosis,
only mild haematological changes were observed. Eosinophilia was absent but the presence of plasma
cells was observed. Neutrophilic leucocytes showed a transient increase but only after treatment. Signs
for coagulopathies were slight; nevertheless coagulation parameters were inoculation dose dependent.
Ten weeks after treatment pulmonary fibrosis was still present. Infections starting from 50 L3 of A.
vasorum had a massive impact on lung tissues and therefore on the health of affected dogs, particularly
after prepatency, although only mild haematological abnormalities were evident.
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Summary 20 
The aim of this comparative study was to investigate the development of clinical signs and 21 
accompanying haematological, coproscopic and pathological findings as a basis for the monitoring 22 
of health condition of Angiostrongylus vasorum infected dogs. Six beagles were orally inoculated 23 
with 50 (n = 3) or 500 (n = 3) A. vasorum third stage larvae (L3) obtained from experimentally 24 
infected Biomphalaria glabrata snails. Two dogs were treated with moxidectin/imidacloprid spot-on 25 
solution and 2 further dogs with an oral experimental compound 92 days post infection (dpi), and 26 
were necropsied 166 dpi. Two untreated control dogs were necropsied 97 dpi. Prepatency was 47-27 
 2 
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49 days. Dogs inoculated with 500 L3 exhibited earlier (from 42 dpi) and more severe respiratory 28 
signs. Clinical signs resolved 12 days after treatment and larval excretion stopped within 20 days in 29 
all 4 treated dogs. Upon necropsy, 10 and 170 adult worms were recovered from the untreated 30 
dogs inoculated with 50 and 500 L3, respectively Adult worms were also found in two treated dogs, 31 
in the absence of L1 or eggs. Despite heavy A. vasorum infection load and severe pulmonary 32 
changes including vascular thrombosis, only mild haematological changes were observed. 33 
Eosinophilia was absent but the presence of plasma cells was observed. Neutrophilic leucocytes 34 
showed a transient increase but only after treatment. Signs for coagulopathies were slight, 35 
nevertheless coagulation parameters were inoculation dose dependent. Ten weeks after treatment 36 
pulmonary fibrosis was still present. Infections starting from 50 L3 of A. vasorum had a massive 37 
impact on lung tissues and therefore on the health of affected dogs, particularly after prepatency, 38 
although only mild haematological abnormalities were evident. 39 
 40 
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1. Introduction 45 
Angiostrongylus vasorum is a metastrongylid nematode that resides as adult stage (13-21 mm) in 46 
the pulmonary arteries and the right ventricle, atrium and auricle of the heart in dogs and other 47 
carnivores. Snails and slugs are obligatory intermediate hosts (Guilhon and Bressou, 1960; Eckert 48 
and Lämmler, 1972). The distribution of A. vasorum encompasses Europe, South and North 49 
America and Africa. Isolated endemic foci are generally observed throughout these regions 50 
although increasingly reports of infections outside of these focal areas have been documented 51 
(reviewed in Koch and Willesen, 2009). 52 
Clinical manifestations of A. vasorum infection in dogs are highly variable. Respiratory signs 53 
induced by verminous pneumonia are very frequent. Other signs may include coagulopathies with 54 
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bleeding disorders, neurological, gastrointestinal or non specific signs such as anorexia and 55 
exercise intolerance. Sudden death may also occur due to the obstruction of the pulmonary or other 56 
important arteries or heart failure (Mason, 1987; Patteson et al., 1993; Cury and Lima, 1996; 57 
Ramsey et al., 1996; Chapman et al., 2004; Garosi et al., 2005; Staebler et al., 2005; Wessmann et 58 
al., 2006). Naturally infected asymptomatic dogs have also been reported (Martin et al., 1993; 59 
Patteson et al., 1993; van Doorn et al., 2009). In a study with 20 naturally infected dogs, 10% of the 60 
dogs showed anaemia, 40% had neutrophilic leukocytosis, 45% eosinophilia, 30% monocytosis, 61 
15% lymphocytosis and a fourth of the dogs had basophilia (Chapman et al., 2004). Also 62 
hypercalcaemia (Boag et al., 2005), low serum fructosamine concentrations (Willesen et al., 2006) 63 
and other haematological factors, reviewed by Koch and Willesen (2009), have been associated 64 
with angiostrongylosis. Since also coagulopathies have been repeatedly reported in naturally 65 
infected dogs (Chapman et al., 2004; Garosi et al., 2005; Wessmann et al., 2006), testing of the 66 
coagulation system is recommended when a progressed case of angiostrongylosis is suspected 67 
(Koch and Willesen, 2009). The main parameters for the detection of coagulation dysfunctions 68 
include one-stage prothrombin time (PT), the activated partial thromboplastin time (aPTT), platelet 69 
counts and occasionally, thrombin time (TT) and fibrin degradation products. However 70 
haematological and chemical changes have been shown to exhibit high variation between different 71 
studies with naturally infected dogs (Bolt et al., 1994). The infection time(s) and worm burden are 72 
important unknown factors occurring during natural infections. They are possibly responsible for 73 
these variations and can be further influenced by an individual’s immunological state and 74 
concomitant infections and diseases.  75 
Experimental studies allowed following up the course of haematological and coagulation 76 
parameters during A. vasorum infection, however contradictory results were described in such 77 
studies. Additionally these parameters were not correlated with onset of clinical signs, coproscopic 78 
findings and pathological manifestations (Prestwood et al., 1981; Schelling et al., 1986; Cury et al., 79 
2002). The aim of this comparative study was to investigate the development of clinical signs and 80 
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accompanying haematological, coproscopic and pathological findings as a basis for the monitoring 81 
of health condition of A. vasorum infected dogs in upcoming treatment studies.  82 
 83 
2. Materials and Methods 84 
2.1 Study design, experimental inoculation 85 
Six healthy facility-born beagle dogs, with a body weight of 10.8-16.2 kg were experimentally 86 
inoculated with L3 of A. vasorum on study day 0. Dogs were both males (n = 2) and females (n = 4) 87 
aged 2 (n = 5) or 6 years (n =1) Larvae were obtained from experimentally infected snails 88 
(Biomphalaria glabrata) and isolated as previously described (Schnyder et al., 2009). Dogs were 89 
randomly divided into two groups. Three dogs received 50 L3 (Group A, dog A1, A2, A3) and 3 90 
dogs received 500 L3 (Group B, dog B1, B2, B3), orally by mixing with wet cat food. Two dogs (A1 91 
and B1) were euthanized 97 days post inoculation (dpi). Two dogs (A2, B2) were treated 92 dpi 92 
with imidacloprid/moxidectin (Advocate®, Bayer Animal Health) applied at the minimum 93 
recommended dosage of 0.1 ml per kg body weight. Two dogs (A3, B3) were also treated 92 dpi 94 
with an experimental compound (EC) in oral tablet form. Treated dogs were euthanized 166 dpi. 95 
 96 
2.2 Clinical follow-up 97 
All dogs underwent physical examination by a veterinarian before inoculation and then weekly 98 
starting from 4 days post inoculation (dpi) until 84 dpi (all dogs), then 104, 111, 119 and 126 dpi (4 99 
dogs). Reference values for rectal temperature, heart rate and respiratory rate were previously 100 
obtained from a set of 96 values from healthy dogs of the same breed housed at the same 101 
institution. Weight of the dogs was determined before and at 63, 70, 77 dpi.  102 
Additionally, starting on 42 dpi, mucous membranes, heart rate, rectal temperature, lymph nodes 103 
and respiration were assessed weekly in all dogs. The respiration assessment included the 104 
intensity of inspiratory and expiratory sounds on a scale from 0 to 3 (0= no sound; 1= slight sound; 105 
2= moderate sound; 3= severe sound), the quality of the respiratory sound (normal / deepened 106 
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normal sound / stertor / stridor / rhonchus / wheeze / crackle), abdominal involvement and 107 
cough/retch (yes or no). 108 
 109 
2.3 Coproscopic examination 110 
A faecal examination from each dog was performed before inoculation using combined 111 
sedimentation/flotation and the Baerman-Wetzel larval emigration technique (Eckert et al., 2008) in 112 
order to exclude intestinal parasite infestations. Starting from 42 to 89 dpi, faeces were collected 113 
daily from each dog and examined for shedding of L1 of A. vasorum by Baerman-Wetzel technique. 114 
From 90-92 dpi (before chemotherapy) and from 92-110 dpi (after chemotherapy) the number of L1 115 
per gram of faeces (LPG) was determined by the same method in 10 grams of faeces. Afterwards, 116 
faeces were analyzed every second day until 140 dpi, then weekly until the study end (166 dpi).  117 
 118 
2.4 Haematology and coagulation analysis 119 
Venous blood samples were collected from all dogs during the study in intervals of 3-7 days until 77 120 
dpi, later on 91, 104 and 111 dpi. Samples were immediately forwarded to the clinical laboratory of 121 
the Vetsuisse Faculty, University of Zurich, for haematological and coagulation analysis. A 122 
complete blood cell count (CBC) was performed using EDTA-anticoagulated blood in a 123 
haematology analyzer (CellDyn 3500, Abbott, Baar, Switzerland) and a manual white blood cell 124 
differential. Citrated plasma was used to determine prothrombin time (PT), thrombin time (TT), and 125 
activated partial thromboplastin time (aPTT) by automated analysis (Start 4, Roche Diagnostics, 126 
Rotkreuz, Switzerland). 127 
 128 
2.5 Post mortem examination 129 
Adult worm burdens were determined by reverse lung perfusion and dissection applying a method 130 
described previously (Schnyder et al., 2009). The extent and severity of pneumonic change was 131 
assessed semi-quantitatively using a scale from “+” to “+++” (“+” = slight; “++” = moderate; “+++” = 132 
severe). Tissue samples from affected areas were removed from each lung and fixed in formalin for 133 
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subsequent histological examination. The sections were graded according to the extent of 134 
pneumonic alteration, frequency of thrombi and the presence of parasites using the same scale.  135 
 136 
2.6 Statistical analysis 137 
Statistical analysis was performed using GraphPad Prism version 4.00 for Windows, GraphPad 138 
Software, San Diego California USA, www.graphpad.com. To give an overview about trends, 139 
comparison of means of group A and B concerning haematological and coagulation results and 140 
LPG before treatment was made using a non-parametric Mann-Whitney test. The level of 141 
significance was set at 0.05. 142 
 143 
3. Results 144 
3.1 Clinical follow-up 145 
The heart rate of the dogs did not significantly change during the study and ranged from 72-146 
144/min. Intermittent elevated rectal temperature up to 40.5 C° in 5 of 6 dogs was observed.  147 
Before inoculation the mean respiratory rate in the 6 dogs was 25 (range 10-32). The respiratory 148 
rate significantly increased during the study to a maximum of 58 (32-92) at 63 dpi. Forced 149 
respiration and increased respiratory sounds were first detected in dog B3 at 42 dpi and in all dogs 150 
from group B at 49 dpi. In group A these symptoms were observed starting between 49 to 56 dpi. 151 
Signs tended to be stronger in dogs of group B and were still present at 92 dpi, although respiratory 152 
signs tended to improve. Faeces containing blood were observed during the study, particularly 153 
between 77-84 dpi in dogs of group B. Loss of appetite was common. Five out of six dogs showed 154 
weight loss. Two dogs in group A had a weight loss of 1 and 7%, while all dogs in group B had 155 
presented weight loss (7, 12 and 16%, respectively). The difference between groups was 156 
significant. In the treated dogs no more clinical manifestations were observed after 104 dpi, i.e. 12 157 
days after treatment. 158 
 159 
3.2 Coproscopic examination  160 
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Faecal examination before experimental inoculation was negative. Larval shedding started from 47 161 
dpi (dog B2), 48 dpi (dogs A1, A2, B3) and 49 dpi (dogs A3, B1) and was constantly positive until 162 
necropsy or treatment. LPG before chemotherapy on 90-92 dpi was 30-1608 (mean, standard 163 
deviation (SD): 317, 469) and 306-16992 (mean, SD: 2764, 5171) in dogs of group A and B, 164 
respectively. This difference between groups was however, not significant (p = 0.20). After 165 
chemotherapy, LPG in dogs treated with imidacloprid/moxidectin decreased from 678 to 0 (dog A2) 166 
and from 2976 to 0 (dog B2), both within 15 days. In dogs treated with EC, the LPG decreased from 167 
30 to 0 in 20 days (dog A3), and from 7278 to 0 in 15 days in dog B3. No larvae were found from 21 168 
days after treatment (113 dpi) until the study end (day 166). 169 
 170 
3.3 Haematology and coagulation analysis 171 
Over the course of the experimental infection, only mild changes in the CBCs were observed for 172 
both groups. The PCV (packed cell volume) showed a mild decrease after patency (63 dpi, data not 173 
shown). Dogs of group B tended to show lower PCV values than group A. Most dogs showed an 174 
occasionally mild neutrophilic leucocytosis starting around 21 dpi. Instead, 12 days after treatment 175 
(104 dpi) all four dogs developed a significant (p < 0.001) transient and mild to moderate 176 
neutrophilic leucocytosis (Fig. 1a) compared to values of the six dogs before inoculation. The 177 
eosinophil count did not show a clear increase but rather fluctuated over time (Fig. 1b). Notably one 178 
dog of group B (B1) had eosinophil counts mildly above the reference range already before 179 
inoculation and two occasions at 42 and 35 dpi. There was a mild increase in the monocyte count in 180 
4 out of 6 dogs (A1, A2, B1, B3) on 1-3 occasions starting from 56 dpi (Fig. 1c). The lymphocyte 181 
count was essentially unchanged throughout the study, except after treatment, where there was a 182 
mild increase, comparable to the neutrophil count (data not shown). In 4 dogs (A1, A2, B1, B3), an 183 
occasional mild basophilia at 1-5 time points between 42-104 dpi was observed, but never above 184 
0.28x10(3)/µl (Fig. 1d). Basophils were more often (6 of 46 CBCs) above the reference range in 185 
dogs in group B as compared to values of dogs in group A (3 of 46 CBCs). In the blood smear of 186 
dog A1, plasma cells were found 70 dpi (60/µl).  187 
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The coagulation times PT, aPTT and TT were essentially within reference ranges throughout the 188 
experiment. In dogs B1 and B2, PT and aPTT were once minimally above the upper reference 189 
range, respectively. Nevertheless aPTT (Fig. 2a) was significantly higher in group B on 63 and 70 190 
dpi (p= 0.024 and 0.02, respectively). Platelets were often clustered, preventing accurate counts at 191 
some time points. The platelet counts (Fig. 2b) remained virtually in the normal range during the 192 
study, even though there was a decline starting around patency in all dogs. A mild to moderate 193 
thrombocytopenia was observed in 3 individual dogs (A2, B1, B2) between 49-70 dpi and the 194 
number of thrombocytes was significantly lower in group B on 77 and 91 dpi (p= 0.017 and 0.015, 195 
respectively). 196 
 197 
3.4 Post mortem examination  198 
The number of adult specimens of A. vasorum recovered by reverse lung perfusion and the extent 199 
of the gross and histological lesions for each dog are summarized in Table 1. Approximately 80% of 200 
the lungs of the two untreated animals necropsied 97 dpi (dogs A1 and B1) were consolidated (Fig. 201 
3a) and their appearance was macroscopically similar. All the lobes contained large, confluent, firm 202 
and raised nodules that were irregularly discoloured from pale beige to brownish-yellow and 203 
frequently associated with dark red hemorrhagic patches. The pleural surface of some nodules had 204 
a gray translucent centre. The cut surface in the less affected areas appeared granular (Fig. 3b). In 205 
contrast, lung tissue of the treated dogs was far less affected, usually restricted to disseminated 206 
pale beige slightly raised foci (~ 1cm diameter) and areas of yellowish discoloration in the aerated 207 
tissues (Fig. 4). An exception was dog B2, whose lungs still manifested hemorrhagic patches, foci 208 
with gray translucent centres and remnants of fibrous adhesions. The lung lymph nodes were 209 
consistently enlarged and moist in both treated and untreated dogs.  210 
Histological sections confirmed that the consolidated lung tissues of untreated dogs were totally 211 
solidified and consisted mainly of masses of plasma cells and macrophages (Fig. 5a). When 212 
thrombi were present they were often associated with incorporated larvae and eggs (Fig. 5b). 213 
Often, the arterial walls were thickened. The granulomas consisted mainly of macrophages, 214 
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multinucleated giant cells and lymphocytes that had accumulated around larvae and eggs and were 215 
associated with pneumocyte proliferation, haemorrhage and intracellular hemosiderin (Fig. 5c). 216 
Eosinophilic granulocytes were present only very sporadically. In the dogs treated 92 dpi and 217 
euthanized 166 dpi, pneumonia and fibrosis were still present (Fig. 5d), but to a lesser extent. No 218 
parasitic stages were histologically present in 3 out of the 4 treated dogs. One treated dog (dog A3) 219 
had only adult worms in a larger vessel. Differences between dogs of group A and B concerning 220 
gross and histological lesions were not obvious, with the exception of fibrosis which was more 221 
pronounced in group B. 222 
 223 
4. Discussion 224 
This study correlates the successful experimental infection of six dogs with two different A. vasorum 225 
L3 inoculation doses of A. vasorum, leading to severe clinical and pathological manifestations on 226 
one hand, but in contrast with mild haematological and coagulation changes. Animal numbers were 227 
small, due to animal welfare reasons and the study's pilot character intended for further 228 
experimental studies, therefore significant differences were considered cautiously and are 229 
mentioned to highlight trends in several parameters.  230 
 231 
4.1 Pre-treatment 232 
The prepatency of 47-49 days in this study was in the range (38-57 days) of previous observations 233 
(reviewed in Bolt et al., 1994). During patency, the number of detected larvae in the faeces was 234 
variable and therefore did not allow an estimate of the present worm burden, as also shown in 235 
previous studies (Oliveira-Junior et al., 2006). 236 
All dogs in this trial developed respiratory symptoms and the progressive worsening of these clinical 237 
signs was typical for infections with A. vasorum (Koch and Willesen, 2009). Weight loss was higher 238 
and respiratory signs were more pronounced and started earlier (one week before onset of 239 
patency) in dogs of group B, followed one week later by respiratory signs in dogs of group A. This is 240 
in contrast with previous experimental inoculations with similar inoculation doses (Prestwood et al., 241 
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1981; Schelling et al., 1986) and other experimental infections (Neff, 1971) where no clinical 242 
abnormalities suggestive for A. vasorum were noted before patency. In a study performed under 243 
similar conditions as described for this study, with the exception that 200 L3 were administered, 244 
slight to moderate respiratory sounds were observed starting from 41 dpi, confirming that an 245 
attentive physical examination including lung auscultation can furnish indications for A. vasorum 246 
infection before the onset of potential fatal coagulopathies and notably before patency and 247 
therefore aetiological diagnosis by Baerman-Wetzel technique (Schnyder et al., 2009). Indeed 248 
pathological (Neff, 1971; Prestwood et al., 1981) and radiological (Mahaffey et al., 1981) 249 
examinations of experimentally infected animals (always with similar inoculation doses) confirmed 250 
lesions in lungs starting from 13 – 30 days post inoculation, however these changes were not 251 
correlated with clinical signs. Clinical outcome and larval excretion during A. vasorum infection may 252 
be influenced by the age of infected dogs. In studies using naturally infected dogs young animals 253 
are regularly overrepresented (Chapman et al., 2004; Koch and Willesen, 2009) and more often 254 
exhibited severe clinical signs with fatal outcome than older ones (Staebler et al., 2005). Animals of 255 
the presented experimental study were adult dogs and all, including the oldest of 6 years of age, 256 
presented clinical signs and at least temporarily high larval excretion. In an experimental study with 257 
dogs of 1 year of age, larval excretion was very irregular (Oliveira-Junior et al., 2006). We therefore 258 
conclude that the age of affected animals is not a factor helping to predict the course of an 259 
experimental A. vasorum infection and most probably also not in naturally infected dogs. 260 
The anaemia found in the dogs was mild and not detected clinically by observation of a pale 261 
mucosa. Similarly, in another experimental study, young dogs aged 6-8 months receiving 262 
inoculation doses of 50-100 L3/kg BW (Cury et al., 2002) showed PCV values mildly under the 263 
reference range starting from 20 dpi. Our inoculation doses were lower (3.2-4.6 and 31-36 L3/kg 264 
BW for group A and B, respectively) and thus we conclude that even though differences between 265 
groups A and B were observed, anaemia does not clearly develop with inoculation doses of 266 
approximately 500 L3 per dog and can therefore not serve as an indicator for canine 267 
angiostrongylosis.  268 
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A high degree of eosinophilia caused by endoparasitism is often reported in literature. Migration 269 
within the tissue and prolonged host-tissue contact lead to the production of interleukin (IL) 5. Also 270 
a subsequent exposure to the same parasite elicits a quicker and more drastic eosinophilia 271 
(Schultze, 2000). Surprisingly then, eosinophilia was often absent or mild for the dogs in this study. 272 
In addition, no explanation can be provided for one dog presenting with eosinophilia before 273 
inoculation. In previous studies dogs with angiostrongylosis presented with or without eosinophilia 274 
(Cury et al., 2002; Chapman et al., 2004; Willesen et al., 2009). In our study histology of lung 275 
tissues confirmed the very sporadic presence of eosinophilic granulocytes. Therefore it has to be 276 
considered that the absence of eosinophilia does not exclude an A. vasorum infection. 277 
Mild monocytosis started from 56 dpi equally in both groups. This result is in agreement with the 278 
observed leucocytosis and neutrophilia, as each are indicative of chronic inflammation. 279 
Monocytosis due to A. vasorum infection had not been described in experimental infections before 280 
however has been reported in up to 30 % of clinical cases (Chapman et al., 2004) and does not 281 
represent a characteristic sign for canine angiostrongylosis. 282 
Basophilia is rare in dogs and is reported with hypersensitivity or inflammatory conditions (Schultze, 283 
2000). The mild basophilia seen in this study may be a reflection of the high imprecision when 284 
measuring basophiles by blood smear evaluation as this leukocyte subpopulation is often 285 
underrepresented in peripheral blood. However basophilia occurred also in 25 % of dogs naturally 286 
infected with A. vasorum (Chapman et al., 2004) and a frequent reported cause of basophilia is the 287 
infection with another heart worm, Dirofilaria immitis (Rawlings, 1982). Basophils are reported to 288 
respond quickly to inflammatory signals that are induced by helminth infections and can be 289 
recruited into tissues such as lung where they contribute to initiation of protective immunity by local 290 
release of cytokines IL-4, IL5 and IL-13 (Voehringer, 2009).  291 
Plasma cells, indicating generally a humoral B-cell response after antigen-stimulation (Schultze, 292 
2000), are very rarely observed in the peripheral blood circulation in dogs but were detected in the 293 
blood of one dog 70 dpi. The presence of plasma cells associated with A. vasorum infection is, to 294 
our knowledge, described for the first time. Particularly leishmaniosis and ehrlichiosis are reported 295 
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to be associated with intensive B-cell activation and massive presence of plasma cells in concerned 296 
tissues in dogs (Kuehn and Gaunt, 1985; Martinez-Moreno et al., 1993) but this did not implicit the 297 
presence of plasma cells in the peripheral blood circulation. However it can be expected that 298 
plasma cells could be detectable since A. vasorum infection induced the production of circulating 299 
antibodies (Cury et al., 1996; Vasconcelos et al., 2008; Verzberger-Epshtein et al., 2008). 300 
In contrast to previous cited experimental studies (Schelling et al., 1986; Cury et al., 2002) and 301 
several case reports (Dodd, 1973; Ramsey et al., 1996; Garosi et al., 2005; Wessmann et al., 2006; 302 
Schmitz and Moritz, 2009), we only found very limited coagulation abnormalities, coinciding with the 303 
absence of haemorrhages. The only potential signs of coagulopathy observed for the current 304 
experimental infections included occasional blood in faeces and a higher aPTT in highly inoculated 305 
dogs versus dogs inoculated with 50 L3 between 63-70 dpi. 306 
The decrease of platelet counts observed from 42-70 dpi coincides with the onset of patency but 307 
was not clinically relevant. Temporal patterns were very similar to those observed during other 308 
experimental studies with comparable (Schelling et al., 1986) or higher (Cury et al., 2002) 309 
inoculation doses. Our significantly lower values in highly inoculated dogs on 77 and 91 dpi 310 
indicates that thrombocytopenia due to A. vasorum – infections may be dose dependent, a result 311 
that was not detected in a previous experimental infection (Schelling et al., 1986). It is during this 312 
time that adult A. vasorum are established within the pulmonary arteries and are producing eggs 313 
and L1 (Guilhon and Cens, 1973). Such infections may directly cause a reduction in platelet 314 
number however, generalized inflammation may also produce an increased depletion of platelets as 315 
a consequence of consumption coagulopathy (Breitschwerdt, 1988; Grindem et al., 1991). In 316 
contrast to experimental studies, more than half of naturally infected dogs (12/20) exhibited 317 
thrombocytopenia (Chapman et al., 2004). The mechanism of the onset of thrombocytopenia and 318 
generally of bleeding disorders during A. vasorum – infections have been repeatedly discussed but 319 
are still not fully understood (Morgan et al., 2005; Koch and Willesen, 2009). Chronic disseminated 320 
intravascular coagulation (DIC) as a consequence of consumptive coagulopathy (Ramsey et al., 321 
1996), as well as an immune-mediated thrombocytopenia (Gould and McInnes, 1999), von 322 
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Willebrand factor deficiency (Whitley et al., 2005) or accumulation of immune complexes in the lung 323 
vessels stimulating the intrinsic pathway in addition to the secretion of antigens by adult worms and 324 
larvae (Caruso and Prestwood, 1988) have all been suggested as potential influencing factors. 325 
Additional techniques for the diagnosis of coagulopathies and particularly DIC have been previously 326 
considered. In particular, thromboelastography, a method introduced in 1948 (Hartert, 1948), has 327 
been presented as the assay allowing the identification of hypo-, normo- or hypercoagulable 328 
patients (Wiinberg et al., 2009) and is suggested to be a helpful tool to identify also dogs with 329 
coagulopathies due to A. vasorum – infections but devices for this assay are not yet widely 330 
distributed in veterinary laboratories.  331 
 332 
4.2 Post-treatment 333 
Imidacloprid/moxidectin and the EC stopped larval shedding in all four treated dogs within 20 days 334 
until the study end. Potentially sterile, adult parasites were however found in one dog for each 335 
anthelmintic treatment. With imidacloprid/moxidectin a single worm was found in a dog that had 336 
received 500 L3, showing high efficacy. In contrast, one dog inoculated with 50 L3 and treated with 337 
the EC still presented with 13 adults at necropsy. The worms of this dog were apparently not 338 
producing eggs. Particularly larvae and eggs were shown to cause granulomatous pneumonia 339 
(Prestwood et al., 1981, Schnyder et al., 2009). Possibly some anthelmintic treatments may not 340 
completely eliminate adult worms but are able to sterilize them, limiting therefore the pathogenicity 341 
of the infection, as demonstrated by necropsy and the absence of clinical signs 12 days after 342 
treatment in dogs of this study.  343 
Imidacloprid/moxidectin has been previously tested for the treatment of A. vasorum in naturally and 344 
experimentally infected dogs in a single application (Willesen et al., 2007; Schnyder et al., 2009) as 345 
well as milbemycin oxime (0.5mg/kg PO) weekly for four weeks (Conboy, 2004), supporting the 346 
results obtained for two dogs in this study. Macrocyclic lactones are therefore suggested to replace 347 
the classical long-lasting fenbendazole therapy. Pathological observations of the lungs revealed 348 
considerable improvements in gross morphology for 3 of 4 dogs when compared with untreated 349 
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dogs. Tissues for histological analysis were only sampled from affected areas and as such, could 350 
not be used to assess quantitative differences between each of the dog groupings. However, 351 
interestingly, eggs and larvae were only present in untreated dogs. Thrombi and particularly fibrosis 352 
were also still present in the treated dog lungs. Fibrosis represents a reparative process in 353 
response to damage of an organ or a tissue; the substitutive tissue is usually not as functional as 354 
the original tissue, but apparently this did not impact on clinical performances for these dogs. 355 
However, as they were always kept in kennels, the demand for high level exertion was limited.  356 
An interesting outcome is the distinct increase of leucocytes and segmented neutrophils twelve 357 
days after treatment. It may indicate that the elimination of parasitic stages due to treatment 358 
enhanced the inflammatory response in these dogs. Such immune responses were comparable in 359 
dogs of both groups, resolving to baseline values within 34 days after treatment, and, to our 360 
knowledge, have not been described before. Similar patterns were observed for the lymphocytes, 361 
indicating a cellular immune reaction to dead parasites. This is sustained by a study with 42 362 
naturally infected dogs in which leucocytes were within the reference range on the day of 363 
diagnosing A. vasorum, but significantly decreased 42 days after treatment (Willesen et al., 2009).  364 
The results from this study showed that respiratory sounds detected by an attentive auscultation of 365 
the lungs may indicate an early, prepatent infection of A. vasorum in dogs. Clinical signs tended to 366 
be associated with the inoculation doses but were not correlated with the age of the dogs. Despite 367 
heavy A. vasorum infection load and severe pulmonary changes including vascular thrombosis, 368 
only mild haematological changes were observed and without serial measurements they may have 369 
to be considered carefully. The absence of eosinophilia did not exclude an A. vasorum infection and 370 
rarely plasma cells were observed in the peripheral blood circulation. Signs for coagulopathies in 371 
form of a prolonged aPTT and thrombocytopenia were slight and could also be missed without 372 
serial measurements. Nevertheless in this study changes concerning coagulation parameters 373 
showed inoculation dose dependent.  374 
A further important point the practitioners have to consider is that larval excretion may continue for 375 
over 3 weeks, even if anthelmintic treatment was successful. Leucocytosis shortly after treatment 376 
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returning to baseline within five weeks may indicate an enhanced immune response that has not 377 
been previously described. Ten weeks after treatment fibrosis was still present, however this did not 378 
have a clinical impact on the dogs. Possibly some anthelmintic treatments may not completely 379 
eliminate adult worms but be able to sterilize them leading to a reduced pathogenicity of A. 380 
vasorum infection.  381 
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Table 1 506 
Post-mortem findings of treated and untreated dogs after experimental inoculation with 50 (group A) 507 
or 500 (group B) third stage larvae of Angiostrongylus vasorum: gross and histological lesions in 508 
the lungs and adult worms recovered by reverse lung perfusion and dissection of heart and lungs. 509 
 510 
Dog 
ID 
 
Treatment/ 
Necropsy 
(dpi) 
Inoculation 
dose (L3) 
Post-mortem findings 
   Number of 
adult A. 
vasorum 
Gross 
findings3 
Histological findings3 
     Pneumonia Eggs / L1 Thrombi Fibrosis 
A1 None/ 
97 
50 10 +++ +++ +++ + ++ 
A2 921/ 
166 
50 0 + + - - + 
A3 922/ 
166 
50 13 + ++ Adults 
(no larvae) 
+ + 
B1 None/ 
97 
500 170 +++ +++ ++ + + 
B2 921/ 
166 
500 1 ++ ++ - + ++ 
B3 922/ 500 0 + + - + +++ 
 21 
 
21
166 
 511 
1: I/M: imidacloprid / moxidectin (Advocate®). 512 
2: EC (experimental compound). 513 
3: “+” = slight; “++” = moderate; “+++” = severe. 514 
515 
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Figure captions 516 
Fig. 1 517 
Haematological values of six dogs experimentally inoculated with 50 (n=3, group A, dotted lines) or 518 
500 (n=3, group B, continuous lines) third stage larvae of Angiostrongylus vasorum from -6 to 126 519 
days post inoculation (dpi). The arrows (↑) indicate the point of treatment of 4 dogs (A2, A3, B2 and 520 
B3) 92 dpi. Two dogs (A1, B1) were necropsied 97 dpi 521 
(a) Segmented Neutrophils 522 
(b) Eosinophils 523 
(c) Monocytes 524 
(d) Basophils 525 
 526 
Fig. 2 527 
Coagulation profiles of six dogs experimentally inoculated with 50 (n=3, group A, dotted lines) or 528 
500 (n=3, group B, continuous lines) third stage larvae of Angiostrongylus vasorum from -6 to 92 529 
days post inoculation 530 
(a) Activated partial thromboplastin time 531 
(b) Platelet counts 532 
 533 
Fig. 3 534 
Lungs of dog B1, necropsied 97 days after inoculation with 500 third stage larvae of 535 
Angiostrongylus vasorum 536 
(a) Large areas were consolidated and presented firm, raised nodules with dark red hemorrhagic 537 
patches or discoloration to brownish-yellow 538 
(b) The cut surface appeared granular 539 
 540 
 541 
 542 
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Fig. 4 543 
Lungs of dog B3 inoculated with 500 third stage larvae (L3) of Angiostrongylus vasorum, treated 544 
with an anthelmintic experimental compound 92 days post inoculation (dpi) and necropsied 166 dpi. 545 
The lungs exhibit hemorrhagic patches, foci with gray translucent centres and remnants of fibrin 546 
adhesions within the pleura 547 
 548 
Fig. 5 549 
Histological sections (hematoxylin and eosin stain) of lung tissue from dogs inoculated with third 550 
stage larvae (L3) of Angiostrongylus vasorum 551 
(a) Dog B1, necropsied 97 days after inoculation (dpi) with 500 L3: The alveoli are invaded with 552 
masses of plasma cells, macrophages, multinucleated giant cells and lymphocytes 553 
(b) Dog B1: Larval stages are surrounded by a granulomatous inflammation. Thrombi and 554 
thickened arterial walls were regularly present 555 
(c) Dog B1: Granulomas around larvae and eggs were associated with pneumocyte proliferation, 556 
haemorrhage and intracellular hemosiderin 557 
(d) Dog A3, inoculated with 50 L3, treated with an anthelmintic experimental compound 92 dpi and 558 
necropsied 166 dpi. Pneumonia and fibrosis were still present, but to a lesser extent 559 
560 
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